Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Hepatoid carcinoma of the pancreas in a patient with familial adenomatous polyposis.
Journal: BMJ case reports
Published: June 12, 2025
Utility of ligamentum teres hepatis flap reinforcement to prevent postoperative pancreatic fistulas in robotic distal pancreatectomy.
Journal: American journal of surgery
Published: March 29, 2024
The Pancreatic Cancer Early Detection (PRECEDE) Study is a Global Effort to Drive Early Detection: Baseline Imaging Findings in High-Risk Individuals.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: July 25, 2023
Patient and Caregiver Considerations and Priorities When Selecting Hospitals for Complex Cancer Care.
Journal: Annals of surgical oncology
Published: October 12, 2020
Utility of HNF-1B and a panel of lineage-specific biomarkers to optimize the diagnosis of pancreatic ductal adenocarcinoma.
Journal: American journal of cancer research
Published: September 11, 2020
Adjuvant Trametinib Delays the Outgrowth of Occult Pancreatic Cancer in a Mouse Model of Patient-Derived Liver Metastasis.
Journal: Annals of surgical oncology
Published: August 17, 2015
Morbidity and mortality of hepatectomy for benign liver tumors.
Journal: American journal of surgery
Published: October 28, 2014
Morbidity and mortality of pancreaticoduodenectomy for benign and premalignant pancreatic neoplasms.
Morbidity and mortality of pancreaticoduodenectomy for benign and premalignant pancreatic neoplasms.
Journal: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
Published: September 09, 2014
Co-treatment with panitumumab and trastuzumab augments response to the MEK inhibitor trametinib in a patient-derived xenograft model of pancreatic cancer.
Journal: Neoplasia (New York, N.Y.)
Published: March 24, 2014
Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets.
Journal: Annals of surgical oncology
Published: March 12, 2014
Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinib.
Journal: Neoplasia (New York, N.Y.)
Published: October 11, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026